These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 38975190)

  • 1. miR-24-3p and miR-484 are potential biomarkers for neurodegeneration in multiple sclerosis.
    Al-Temaimi R; Alroughani R
    Heliyon; 2024 Jun; 10(12):e32685. PubMed ID: 38975190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of potential microRNA biomarkers for multiple sclerosis.
    Al-Temaimi R; Alshammari N; Alroughani R
    Exp Mol Pathol; 2024 Jun; 137():104903. PubMed ID: 38772208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-132-3p, miR-106b-5p, and miR-19b-3p Are Associated with Brain-Derived Neurotrophic Factor Production and Clinical Activity in Multiple Sclerosis: A Pilot Study.
    Sağır F; Ersoy Tunalı N; Tombul T; Koral G; Çırak S; Yılmaz V; Türkoğlu R; Tüzün E
    Genet Test Mol Biomarkers; 2021 Nov; 25(11):720-726. PubMed ID: 34788141
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum miR-34a-5p, miR-103a-3p, and miR-376a-3p as possible biomarkers of conversion from relapsing-remitting to secondary progressive multiple sclerosis.
    Agostini S; Mancuso R; Citterio LA; Caputo D; Oreni L; Nuzzi R; Pasanisi MB; Rovaris M; Clerici M
    Neurobiol Dis; 2024 Oct; 200():106648. PubMed ID: 39181188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
    Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
    Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiplex Analysis of Cerebrospinal Fluid and Serum Exosomes MicroRNAs of Untreated Relapsing Remitting Multiple Sclerosis (RRMS) and Proposing Noninvasive Diagnostic Biomarkers.
    Mohammadinasr M; Montazersaheb S; Molavi O; Kahroba H; Talebi M; Ayromlou H; Hejazi MS
    Neuromolecular Med; 2023 Sep; 25(3):402-414. PubMed ID: 37020076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of serum miR-191-5p, miR-24-3p, miR-128-3p, and miR-376c-3 in multiple sclerosis patients.
    Vistbakka J; Sumelahti ML; Lehtimäki T; Elovaara I; Hagman S
    Acta Neurol Scand; 2018 Aug; 138(2):130-136. PubMed ID: 29527713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating microRNAs as biomarkers for disease staging in multiple sclerosis.
    Gandhi R; Healy B; Gholipour T; Egorova S; Musallam A; Hussain MS; Nejad P; Patel B; Hei H; Khoury S; Quintana F; Kivisakk P; Chitnis T; Weiner HL
    Ann Neurol; 2013 Jun; 73(6):729-40. PubMed ID: 23494648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte microRNA sequencing reveals differential expression in relapsing-remitting multiple sclerosis.
    Groen K; Maltby VE; Lea RA; Sanders KA; Fink JL; Scott RJ; Tajouri L; Lechner-Scott J
    BMC Med Genomics; 2018 May; 11(1):48. PubMed ID: 29783973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exosomal microRNA signatures in multiple sclerosis reflect disease status.
    Ebrahimkhani S; Vafaee F; Young PE; Hur SSJ; Hawke S; Devenney E; Beadnall H; Barnett MH; Suter CM; Buckland ME
    Sci Rep; 2017 Oct; 7(1):14293. PubMed ID: 29084979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early miR-320b and miR-25-3p miRNA levels correlate with multiple sclerosis severity at 10 years: a cohort study.
    Gonzalez-Martinez A; Bose G; Lokhande H; Saxena S; Healy BC; Polgar-Turcsanyi M; Weiner HL; Chitnis T
    J Neuroinflammation; 2023 Jun; 20(1):136. PubMed ID: 37264432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal variability of serum miR-191, miR-223, miR-128, and miR-24 in multiple sclerosis: A 4-year follow-up study.
    Vistbakka J; Sumelahti ML; Lehtimäki T; Hagman S
    J Neurol Sci; 2022 Nov; 442():120395. PubMed ID: 36084364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of miR-125a-5p and miR-218-5p in Peripheral Blood Mononuclear Cells of Patients with Relapsing-Remitting Multiple Sclerosis.
    Mosarrezaii Aghdam A; Rezaei S; Zarza Nalivan F; Babaie F; Amiri Nikpour MR; Torkamandi S
    Immunol Invest; 2022 Jul; 51(5):1149-1161. PubMed ID: 33866949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-181a-5p is a potential candidate epigenetic biomarker in multiple sclerosis.
    Edgünlü TG; Yılmaz ŞG; Emre U; Taşdelen B; Kuru O; Kutlu G; Erdal ME
    Genome; 2022 Nov; 65(11):547-561. PubMed ID: 36103723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cladribine and ocrelizumab induce differential miRNA profiles in peripheral blood mononucleated cells from relapsing-remitting multiple sclerosis patients.
    Arisi I; Malimpensa L; Manzini V; Brandi R; Gosetti di Sturmeck T; D'Amelio C; Crisafulli S; Ferrazzano G; Belvisi D; Malerba F; Florio R; Pascale E; Soreq H; Salvetti M; Cattaneo A; D'Onofrio M; Conte A
    Front Immunol; 2023; 14():1234869. PubMed ID: 38152407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum ROCK2, miR-300 and miR-450b-5p levels in two different clinical phenotypes of multiple sclerosis: Relation to patient disability and disease progression.
    Ibrahim SH; El-Mehdawy KM; Seleem M; El-Sawalhi MM; Shaheen AA
    J Neuroimmunol; 2020 Oct; 347():577356. PubMed ID: 32781341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential prognostic value of circulating inflamma-miR-146a-5p and miR-125a-5p in relapsing-remitting multiple sclerosis.
    Giuliani A; Lattanzi S; Ramini D; Graciotti L; Danni MC; Procopio AD; Silvestrini M; Olivieri F; Sabbatinelli J
    Mult Scler Relat Disord; 2021 Sep; 54():103126. PubMed ID: 34243103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular miR-145, miR-223 and miR-326 expression signature allow for differential diagnosis of immune-mediated neuroinflammatory diseases.
    Sharaf-Eldin WE; Kishk NA; Gad YZ; Hassan H; Ali MAM; Zaki MS; Mohamed MR; Essawi ML
    J Neurol Sci; 2017 Dec; 383():188-198. PubMed ID: 29246612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA Signature in CSF From Patients With Primary Progressive Multiple Sclerosis.
    Muñoz-San Martín M; Gómez I; Quiroga-Varela A; Gonzalez-Del Río M; Robles Cedeño R; Álvarez G; Buxó M; Miguela A; Villar LM; Castillo-Villalba J; Casanova B; Quintana E; Ramió-Torrentà L
    Neurol Neuroimmunol Neuroinflamm; 2023 Jan; 10(1):. PubMed ID: 36724195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upregulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients.
    Zanoni M; Orlandi E; Rossetti G; Turatti M; Calabrese M; Gomez Lira M; Gajofatto A
    Acta Neurol Scand; 2020 Nov; 142(5):511-516. PubMed ID: 32432792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.